東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Identification of neuroblastoma and ...

Kast, Rachel.

Linked to FindBook

Google Book

Amazon

博客來

Identification of neuroblastoma and its prognostic markers using Raman spectroscopy.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Identification of neuroblastoma and its prognostic markers using Raman spectroscopy./
Author:	Kast, Rachel.
Description:	223 p.
Notes:	Source: Dissertation Abstracts International, Volume: 71-04, Section: B, page: 2532.
Contained By:	Dissertation Abstracts International71-04B.
Subject:	Biology, Biostatistics. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3397861
ISBN:	9781109702620

Identification of neuroblastoma and its prognostic markers using Raman spectroscopy.
Kast, Rachel.

Identification of neuroblastoma and its prognostic markers using Raman spectroscopy. - 223 p.

Source: Dissertation Abstracts International, Volume: 71-04, Section: B, page: 2532.

Thesis (Ph.D.)--Wayne State University, 2010.

Introduction. Neuroblastoma is the most common cancer of infancy. It is one of several peripheral nervous system tumors, including ganglioneuroma, peripheral nerve sheath tumor, and pheochromocytoma. It is commonly situated on the adrenal gland. It displays similar histology to other small round blue cell tumors, including non-Hodgkin lymphoma, rhabdomyosarcoma, and Ewing sarcoma. One method of judging neuroblastoma aggressiveness uses tumor histology factors, including mitosis-karyorrhexis index, Schwannian stromal development, degree of differentiation, and patient age. Tumor aggressiveness can also be judged based on the amplification of certain genes, including MYCN. Raman spectroscopy is a physics-based method which identifies the biochemical fingerprint of a sample. It has recently been applied to disease classification, specifically in adult cancers.

ISBN: 9781109702620Subjects--Topical Terms:

1018416
Biology, Biostatistics.

Identification of neuroblastoma and its prognostic markers using Raman spectroscopy.
LDR:03808nam 2200385 4500 001 1390763
005 20101022135930.5
008 130515s2010 ||||||||||||||||| ||eng d
020 $a 9781109702620
035 $a (UMI)AAI3397861
035 $a AAI3397861
040 $a UMI $c UMI
100 1 $a Kast, Rachel. $3 1669079
245 1 0 $a Identification of neuroblastoma and its prognostic markers using Raman spectroscopy.
300 $a 223 p.
500 $a Source: Dissertation Abstracts International, Volume: 71-04, Section: B, page: 2532.
500 $a Advisers: Gregory W. Auner; Abhilash K. Pandya.
502 $a Thesis (Ph.D.)--Wayne State University, 2010.
520 $a Introduction. Neuroblastoma is the most common cancer of infancy. It is one of several peripheral nervous system tumors, including ganglioneuroma, peripheral nerve sheath tumor, and pheochromocytoma. It is commonly situated on the adrenal gland. It displays similar histology to other small round blue cell tumors, including non-Hodgkin lymphoma, rhabdomyosarcoma, and Ewing sarcoma. One method of judging neuroblastoma aggressiveness uses tumor histology factors, including mitosis-karyorrhexis index, Schwannian stromal development, degree of differentiation, and patient age. Tumor aggressiveness can also be judged based on the amplification of certain genes, including MYCN. Raman spectroscopy is a physics-based method which identifies the biochemical fingerprint of a sample. It has recently been applied to disease classification, specifically in adult cancers.
520 $a Methods. To identify neuroblastoma from adrenal gland, peripheral nervous system tumors, and small round blue cell tumors, and to identify tumor histology, fresh and frozen samples were collected from the operating room and tested with Raman spectroscopy. Tissues were assigned a 'gold standard' diagnosis by experienced pediatric pathologists. Tumor histology was further evaluated with blinded tissues provided by the Children's Oncology Group. To test identification of gene amplification, the tet-on MYCN-3 cell line was cultured in the presence and absence of tetracycline to induce or repress MYCN gene expression. Cells were harvested and tested with Raman spectroscopy and polymerase chain reaction. All Raman spectra were preprocessed and classified with discriminant function analysis.
520 $a Results. Raman spectroscopy identified neuroblastoma from healthy adrenal gland, peripheral nervous system tumors, and small round blue cell tumors with 100% sensitivity and specificity. It identified favorable, unfavorable, and treated neuroblastoma with high accuracy. Neuroblastoma cells with and without MYCN amplification were identified with 100% sensitivity and specificity.
520 $a Conclusions. This is the first study applying Raman spectroscopy to identify pediatric tumors, and the first blinded Raman spectroscopy study performed in collaboration with the Children's Oncology Group, a national tumor bank. It provides the first in-depth examination of specific markers of aggressiveness, including tumor favorability and MYCN gene amplification. Raman spectroscopy has the potential to revolutionize the field of cancer diagnostics. It can provide a detailed, accurate diagnosis in minutes instead of days.
590 $a School code: 0254.
650 4 $a Biology, Biostatistics. $3 1018416
650 4 $a Engineering, Biomedical. $3 1017684
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0308
690 $a 0541
690 $a 0992
710 2 $a Wayne State University. $b Biomedical Engineering. $3 1057465
773 0 $t Dissertation Abstracts International $g 71-04B.
790 1 0 $a Auner, Gregory W., $e advisor
790 1 0 $a Pandya, Abhilash K., $e advisor
790 1 0 $a Klein, Michael D. $e committee member
790 1 0 $a Rabah, Raja $e committee member
790 1 0 $a Ellis, R. Darin $e committee member
790 1 0 $a Cavanaugh, John $e committee member
790 $a 0254
791 $a Ph.D.
792 $a 2010
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3397861